Deciphering the Enigma: A Comprehensive Approach to Evaluating and Managing Acute Chest Pain in Clinical Practice

Introduction

Acute chest pain (ACP) is a common presenting complaint in clinical practice, posing diagnostic and therapeutic challenges to clinicians due to its diverse etiology. Efficient evaluation and management of ACP are critical to prevent adverse outcomes, including myocardial infarction and sudden cardiac death.

Initial Evaluation

Primary assessment involves a detailed history, physical examination, and electrocardiogram (ECG). The history should focus on the character, onset, location, duration, and radiation of pain. Risk factors for coronary artery disease (CAD) should be identified. ECG changes may suggest acute coronary syndromes (ACS).

Diagnostic Testing

Patients with a high pretest probability of ACS should undergo immediate cardiac biomarker testing. High-sensitivity troponin assays have revolutionized the ACS diagnosis, allowing earlier detection of myocardial injury. Noninvasive imaging studies, such as echocardiography or computed tomography coronary angiography (CTCA), can provide further diagnostic clarity in selected cases.

Risk Stratification

Risk stratification tools, such as the HEART score, can guide decision-making. Patients with low-risk scores may be suitable for outpatient management, while those with high-risk scores often require hospitalization and invasive evaluation.

Management Strategies

Management should be tailored to the underlying cause. ACS mandates urgent reperfusion therapy. Non-cardiac causes, such as gastroesophageal reflux disease or musculoskeletal pain, require symptom-specific treatment. Regardless of the cause, all patients should receive education about potential warning symptoms and follow-up arrangements.

Conclusion

In conclusion, ACP evaluation and management require a systematic approach that combines clinical acumen, judicious use of diagnostic tests, and risk stratification. This approach ensures optimal patient outcomes, reducing the morbidity and mortality associated with undiagnosed ACS, while avoiding unnecessary investigations and hospitalizations for patients with non-cardiac chest pain.